Seagen said that the antibody in its ADC may be superior to trastuzumab, as it has a higher affinity for HER2 and gets into cells more effectively, although that will have to be put to the test in ...

Yelena Y. Janjigian, MD, discusses the standard approval of pembrolizumab plus trastuzumab and chemotherapy for the treatment ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

Experts discuss how to manage fatigue, abdominal pain, and other treatment-related symptoms to maintain or improve quality of life for patients undergoing HER2-targeted therapy and share strategies ...

LONDON, March 28 (Reuters) - Jared Kushner's investment company Affinity Partners saw assets under management jump 60% last year to $4.8 billion, according to a regulatory filing, after it ...

The observational study measured how physicians changed treatment plans after seeing HER2DX results and how patients did on the new plans.

Department of Chemical Engineering, Texas A&M University, College Station, Texas 77840, United States ...